Showing results (1441-1450 of 1,573) with videos related to
Sort By:
Pageof 158
Cellular and Molecular Life Sciences : CMLS|May 30, 2023
Cell density-dependent membrane distribution of ganglioside GM3 in melanoma cellsMotohide Murate, Noriko Yokoyama, Nario Tomishige, et al.Scientific Reports|May 29, 2026
CD40.HIVEnv, an antibody mediated vaccine, induces long-term and recall immunogenicity in non-HIV-1 infected volunteersYves Levy, Christiane Moog, Aurélie Wiedemann, et al.Journal of the American Academy of Dermatology|February 8, 2019
Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: A dermatologist and nail expert group consensusDimitrios Rigopoulos, Robert Baran, Soumiya Chiheb, et al.The Lancet. Infectious Diseases|November 20, 2020
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trialAndrew J Pollard, Odile Launay, Jean-Daniel Lelievre, et al.Dermatology and Therapy|January 24, 2020
Correction to: Pathogenesis, Clinical Signs and Treatment Recommendations in Brittle Nails: A ReviewMarco A Chessa, Matilde Iorizzo, Bertrand Richert, et al.Dermatology and Therapy|November 22, 2019
Pathogenesis, Clinical Signs and Treatment Recommendations in Brittle Nails: A ReviewMarco A Chessa, Matilde Iorizzo, Bertrand Richert, et al.Hepatology Communications|March 7, 2020
The Transcription Factor Promyelocytic Leukemia Zinc Finger Protein Is Associated With Expression of Liver-Homing Receptors on Human Blood CD56bright Natural Killer CellsLeonard U Hess, Glòria Martrus, Annerose E Ziegler, et al.Archives of Neurology|June 11, 2008
Reduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosisChitra Krishnan, Adam I Kaplin, Robert A Brodsky, et al.Gastroenterology|July 23, 2018
Interactions Between KIR3DS1 and HLA-F Activate Natural Killer Cells to Control HCV Replication in Cell CultureSebastian Lunemann, Anja Schöbel, Janine Kah, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 25, 2022
T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 TrialLaura Richert, Jean-Daniel Lelièvre, Christine Lacabaratz, et al.Pageof 158